Stryker launches LIFEPAK CR2 defibrillator in US

The FDA has granted the Premarket Approval for Stryker’s LIFEPAK CR2 defibrillator with LIFELINKcentral AED program manager, in the US, following its introduction in Canada, Europe and Japan.
LIFEPAK CR2 AED uses cprINSIGHT technology that allows chest compressions to continue during ECG analysis, increasing the hands-on time and reducing the longest pauses in CPR. The device has a mode button that reduces defibrillation energy for pediatric patients, and an option to toggle to a second pre-set language. It also facilitates remote monitoring and management of battery capacity and expired electrodes to ensure it is always ready to use when needed.
Ryan Landon, Stryker’s emergency care public access vice president and general manager, said: “In order to save more lives from sudden cardiac arrest, we must save time. The LIFEPAK CR2 is designed to help rescuers provide higher quality CPR and to provide the fastest first shock when defibrillation is needed. Everything about it is designed to increase user confidence. The LIFEPAK CR2 harnesses the benefits of connectivity to provide a foundation for better care throughout the entire chain of survival and to simplify AED program management for our customers.”